1. Home
  2. RGCO vs HURA Comparison

RGCO vs HURA Comparison

Compare RGCO & HURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGCO
  • HURA
  • Stock Information
  • Founded
  • RGCO 1912
  • HURA 2009
  • Country
  • RGCO United States
  • HURA United States
  • Employees
  • RGCO N/A
  • HURA N/A
  • Industry
  • RGCO Oil & Gas Production
  • HURA
  • Sector
  • RGCO Utilities
  • HURA
  • Exchange
  • RGCO Nasdaq
  • HURA Nasdaq
  • Market Cap
  • RGCO 209.3M
  • HURA 171.7M
  • IPO Year
  • RGCO N/A
  • HURA N/A
  • Fundamental
  • Price
  • RGCO $20.34
  • HURA $2.55
  • Analyst Decision
  • RGCO
  • HURA Strong Buy
  • Analyst Count
  • RGCO 0
  • HURA 2
  • Target Price
  • RGCO N/A
  • HURA $11.50
  • AVG Volume (30 Days)
  • RGCO 12.3K
  • HURA 130.4K
  • Earning Date
  • RGCO 08-04-2025
  • HURA 08-15-2025
  • Dividend Yield
  • RGCO 4.08%
  • HURA N/A
  • EPS Growth
  • RGCO N/A
  • HURA N/A
  • EPS
  • RGCO 1.29
  • HURA N/A
  • Revenue
  • RGCO $91,314,087.00
  • HURA N/A
  • Revenue This Year
  • RGCO $10.87
  • HURA N/A
  • Revenue Next Year
  • RGCO $3.26
  • HURA $69.15
  • P/E Ratio
  • RGCO $15.73
  • HURA N/A
  • Revenue Growth
  • RGCO 9.74
  • HURA N/A
  • 52 Week Low
  • RGCO $19.05
  • HURA $1.80
  • 52 Week High
  • RGCO $24.20
  • HURA $13.13
  • Technical
  • Relative Strength Index (RSI)
  • RGCO 45.32
  • HURA N/A
  • Support Level
  • RGCO $20.19
  • HURA N/A
  • Resistance Level
  • RGCO $21.61
  • HURA N/A
  • Average True Range (ATR)
  • RGCO 0.53
  • HURA 0.00
  • MACD
  • RGCO 0.00
  • HURA 0.00
  • Stochastic Oscillator
  • RGCO 12.41
  • HURA 0.00

About RGCO RGC Resources Inc.

RGC Resources Inc is involved in the business of distribution and sale of natural gas to residential, commercial, and industrial customers within its service territory in Roanoke, Virginia, and its surrounding localities. The company also provides certain non-regulated services. The company relies on multiple interstate pipelines to transport natural gas. The company operates in three segments: Gas Utility, which is the key revenue generator; Investment in Affiliates this segment reflects the income generated through the activities of the Company's investment in MVP and Southgate projects and Parent & Other including the unregulated activities of the Company as well as certain corporate eliminations.

About HURA TuHURA Biosciences Inc. Common Stock

TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.

Share on Social Networks: